Skip to Main Content

Paper Details

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.
JCI Insight
35
2021
AKB-9778, Angpt-2, COVID-19, Endothelial dysfunction, HUVECs, Primary HUVECs, Tie2, Tie2 receptor, angiopoietin, angiopoietin-2, antithrombotic genes, endothelial, endothelial cells, endothelial dysfunction, microvascular thrombosis, patients, primary endothelial cells, prothrombotic, thromboinflammatory genes
Author NameAffiliation
Dan H BarouchBeth Israel Deaconess Medical Center
Dan H BarouchCenter for Virology and Vaccine Research
Nathan I ShapiroBeth Israel Deaconess Medical Center and Harvard Medical School
Robert E GersztenBeth Israel Deaconess Medical Center and Harvard Medical School
Samir M ParikhBeth Israel Deaconess Medical Center and Harvard Medical School
Samir M ParikhUniversity of Texas Southwestern
Samir M ParikhBeth Israel Deaconess Medical Center and Harvard Medical School
Samir M ParikhUniversity of Texas Southwestern
  • 1 - 8

Datasets

Release 1.2